Taro Pharm Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for TARO PHARM, and when can generic versions of TARO PHARM drugs launch?
TARO PHARM has sixty-one approved drugs.
There are seven US patents protecting TARO PHARM drugs. There are three tentative approvals on TARO PHARM drugs.
There are twenty patent family members on TARO PHARM drugs in nine countries and fifty-six supplementary protection certificates in fourteen countries.
Summary for Taro Pharm
International Patents: | 20 |
US Patents: | 7 |
Tradenames: | 44 |
Ingredients: | 42 |
NDAs: | 61 |
Patent Litigation for Taro Pharm: | See patent lawsuits for Taro Pharm |
Drugs and US Patents for Taro Pharm
Expired US Patents for Taro Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | See Plans and Pricing |
Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | See Plans and Pricing |
Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 6,528,086 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO PHARM drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
International Patents for Taro Pharm Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 101287374 | See Plans and Pricing |
China | 102834096 | See Plans and Pricing |
Canada | 2822220 | See Plans and Pricing |
European Patent Office | 2523660 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2007005988 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2006130510 | See Plans and Pricing |
European Patent Office | 1888026 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Pharm Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1519731 | 13C0067 | France | See Plans and Pricing | PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215 |
0463756 | 99C0007 | Belgium | See Plans and Pricing | PRODUCT NAME: SILDENAFIL, NATL REGISTRATION NO/DATE: EU/1/98/077/001 19980914; FIRST REGISTRATION: CH 54642 19980622 |
2506844 | 1890025-8 | Sweden | See Plans and Pricing | PRODUCT NAME: COMBINATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF UMECLIDINIUM (E.G. UMECLIDINIUM BROMIDE), VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEROF (E.G. VILANTEROL TRIFENATATE) AND FLUTICASONE FUROATE.; REG. NO/DATE: EU/1/17/1236 20171117 |
0152897 | 2001C/013 | Belgium | See Plans and Pricing | PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115 |
0152897 | SPC/GB01/012 | United Kingdom | See Plans and Pricing | PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115 |
1304992 | PA2013025 | Lithuania | See Plans and Pricing | PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323 |
1519731 | 92269 | Luxembourg | See Plans and Pricing | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.